Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Nov. 30, 2021 |
Nov. 30, 2020 |
Nov. 30, 2021 |
Nov. 30, 2020 |
|
| Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) | ||||
| Revenue | $ 0 | $ 0 | $ 0 | $ 0 |
| Expenses | ||||
| Research and development (Note 14) | 6,835,304 | 6,274,283 | 20,757,937 | 10,504,093 |
| General and administrative (Note 15) | 3,091,255 | 2,724,016 | 9,368,052 | 6,726,339 |
| Write-down and impairment of property, plant and equipment | 0 | 5,034,606 | 0 | 5,043,120 |
| Depreciation and amortization (Notes 6 and 7) | 135,035 | 104,307 | 407,806 | 654,354 |
| Interest expense and other financial (income) expenses (Note 19) | 49,655 | (41,855) | 113,344 | 26,016 |
| Interest income | (23,654) | (20,008) | (41,828) | (78,394) |
| Foreign exchange loss (gain) | 10,648 | 95,644 | 42,712 | 275,903 |
| Total expenses | 10,098,243 | 14,170,993 | 30,648,023 | 23,151,431 |
| Net Loss | (10,098,243) | (14,170,993) | (30,648,023) | (23,151,431) |
| Other comprehensive income (loss) | ||||
| Foreign currency translation adjustment | (13,473) | 66,170 | (160,371) | 298,570 |
| Comprehensive loss | $ (10,111,716) | $ (14,104,823) | $ (30,808,394) | $ (22,852,861) |
| Loss per share | ||||
| Basic and Diluted | $ (0.21) | $ (0.34) | $ (0.69) | $ (0.57) |
| Weighted average common shares outstanding | ||||
| Basic and Diluted | 47,264,646 | 41,715,806 | 44,600,557 | 40,515,885 |